HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giacomo Buscemi Selected Research

VRX0466617

3/2007Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giacomo Buscemi Research Topics

Disease

5Neoplasms (Cancer)
03/2022 - 12/2014
4Ataxia Telangiectasia (Louis Bar Syndrome)
10/2012 - 10/2003
3Carcinogenesis
03/2022 - 12/2014
3Breast Neoplasms (Breast Cancer)
10/2020 - 10/2012
3Chromosomal Instability (Chromosome Stability)
07/2015 - 02/2008
1Genomic Instability
01/2019
1Wilms Tumor (Wilm's Tumor)
01/2016
1Aneuploidy (Aneuploid)
02/2008

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
07/2015 - 08/2009
3Phosphotransferases (Kinase)IBA
10/2012 - 10/2003
2DNA (Deoxyribonucleic Acid)IBA
10/2020 - 11/2006
2Nuclear Proteins (Protein, Nuclear)IBA
10/2012 - 10/2003
1Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2020
1TransferasesIBA
01/2019
1Lysine (L-Lysine)FDA Link
01/2019
1Tumor Suppressor Protein p53IBA
01/2019
1CarcinogensIBA
04/2018
1POU Domain FactorsIBA
01/2016
1Sirtuin 1IBA
10/2012
1NAD (NADH)IBA
10/2012
1Ki antigenIBA
02/2008
1Proteasome Endopeptidase Complex (Proteasome)IBA
02/2008
1VRX0466617IBA
03/2007
1Threonine (L-Threonine)FDA Link
11/2006
1Serine (L-Serine)FDA Link
11/2006

Therapy/Procedure

2Therapeutics
03/2022 - 12/2014